René Bernards
2023
In 2023, René Bernards earned a total compensation of $62.5K as Director at LIXTE BIOTECHNOLOGY HOLDINGS, a 53% decrease compared to previous year.
Compensation breakdown
| Other | $62,500 |
|---|---|
| Total | $62,500 |
Bernards received $62.5K in other compensation, accounting for 100% of the total pay in 2023.
Rankings
In 2023, René Bernards' compensation ranked 2,736th out of 2,790 executives tracked by ExecPay. In other words, Bernards earned more than 1.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,736 out of 2,790 | 2nd |
Division Manufacturing | 1,513 out of 1,530 | 1st |
Major group Chemicals And Allied Products | 861 out of 869 | 1st |
Industry group Drugs | 825 out of 832 | 1st |
Industry Pharmaceutical Preparations | 592 out of 597 | 1st |
Source: SEC filing on November 4, 2024.
Bernards' colleagues
We found four more compensation records of executives who worked with René Bernards at LIXTE BIOTECHNOLOGY HOLDINGS in 2023.